Pemphigus vulgaris (PV) autoantibodies directly inhibit desmoglein (Dsg) 3-mediated transinteraction. Because cellular signaling also seems to be required for PV pathogenesis, it is important to characterize the role of direct inhibition in pemphigus acantholysis to allow establishment of new therapeutic approaches. Therefore, we modeled the Dsg1 and Dsg3 sequences into resolved cadherin structures and predicted peptides targeting the adhesive interface of both Dsg3 and Dsg1. In atomic force microscopy single molecule experiments, the selfdesigned cyclic single peptide specifically blocked homophilic Dsg3 and Dsg1 transinteraction, whereas a tandem peptide (TP) consisting of two combined single peptides did not. TP did not directly block binding of pemphigus IgG to their target Dsg antigens but prevented PV-IgG-induced inhibition of Dsg3 transinteraction in cell-free (atomic force microscopy) and cell-based (laser tweezer) experiments, indicating stabilization of Dsg3 bonds. Similarly, PV-IgG-mediated acantholysis and disruption of Dsg3 localization in HaCaT keratinocytes was partially blocked by TP. This is the first evidence that direct inhibition of Dsg3 binding is important for PV pathogenesis and that peptidomimetics stabilizing Dsg transinteraction may provide a novel approach for PV treatment.
Autoantibodies in pemphigus vulgaris (PV)4 are mainly directed against the adhesion molecules desmoglein (Dsg) 3 and Dsg1 (1, 2). Recently, we provided direct evidence that PV autoantibodies directly block Dsg3 transinteraction (3). In contrast, Dsg1 autoantibodies in pemphigus foliaceus (PF) were found to disrupt Dsg1 transinteraction most likely via cellular signaling events rather than by direct inhibition (3, 4). However, it still remained unanswered whether direct inhibition of Dsg3 transinteraction is the sole pathogenic mechanism in mucosaldominant PV where autoantibodies against Dsg3 but not against Dsg1 are present (1). Alternatively, direct inhibition could act in concert with autoantibody-induced cellular signaling or may just be an epiphenomenon secondary to skin blistering (1, 5-7).The idea of direct interference with Dsg transinteraction by pemphigus autoantibodies has been proposed when Dsg3 was discovered to be a cadherin-type cell adhesion molecule (8, 9). From structural and mutational analyses, it was concluded that classical cadherins are able to form adhesive dimers through their N-terminal cadherin extracellular domain (EC1) via different interaction schemes (10 -13). Investigations of desmosomes using electron tomography from tissue sections also indicated various interaction models for desmosomal cadherins (14). Some of these interaction models resembled the interaction schemes found in the high resolution crystal structure analyses of N-and E-cadherin.This study was designed to modulate Dsg3 and Dsg1 transinteraction by using peptides fitting the most likely Dsg adhesive interface revealed by three-dimensional modeling. In an earlier study, it was reported that peptides targeting the putativ...